Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D.
Saved in:
| Title: | Treatment response to bulevirtide is linked to amelioration of portal hypertension in patients with chronic hepatitis D. |
|---|---|
| Authors: | Sandmann L; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.; D-SOLVE Consortium, An EU Horizon Europe-funded Project (no. 101057917), Hannover, Germany.; Excellence Cluster RESIST, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany., Jachs M; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Tergast TL; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany., Hartl L; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Bremer B; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany., Kabelitz MA; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany., Schwarz M; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Egge JFM; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany., Balcar L; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Hofer BS; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Falk CS; German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany.; Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany., Stättermayer AF; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Cornberg M; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.; D-SOLVE Consortium, An EU Horizon Europe-funded Project (no. 101057917), Hannover, Germany.; Excellence Cluster RESIST, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany.; Center of Individualised Infection Medicine, A Joint Venture Between Helmholtz-Centre for Infection Research and Hannover Medical School, Hannover, Germany., Trauner M; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Deterding K; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany., Mandorfer M; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Wedemeyer H; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.; D-SOLVE Consortium, An EU Horizon Europe-funded Project (no. 101057917), Hannover, Germany.; Excellence Cluster RESIST, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany., Reiberger T; Vienna Hepatic Hemodynamic Lab, Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria.; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, Austria., Maasoumy B; Department of Gastroenterology, Hepatology, Infectious Diseases and Endocrinology, Hannover Medical School, Hannover, Germany.; Excellence Cluster RESIST, Hannover Medical School, Hannover, Germany.; German Center for Infection Research (DZIF), Hannover/Braunschweig, Germany. |
| Source: | JHEP reports : innovation in hepatology [JHEP Rep] 2025 Oct 17; Vol. 8 (1), pp. 101643. Date of Electronic Publication: 2025 Oct 17 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101761237 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5559 (Electronic) Linking ISSN: 25895559 NLM ISO Abbreviation: JHEP Rep Subsets: In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
